durapatite has been researched along with diclofenac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, JW; Lim, CF; Raggatt, LE; Stockigt, JR; Topliss, DJ | 1 |
| Djerf, K; Ivarsson, I; Jacobsson, SA; Wahlström, O | 1 |
| Campana, V; Gavotto, A; Moya, M; Palma, J; Simes, J; Soriano, F; Soriano, M; Soriano, R; Spitale, L | 1 |
| Castro, PML; Márquez Brazón, E; Moreira, IS; Piccirillo, C | 1 |
| Chen, Y; Cui, L; Guo, W; Sun, Y; Wang, M; Xu, N; Yan, Y | 1 |
1 trial(s) available for durapatite and diclofenac
| Article | Year |
|---|---|
Photobiomodulation of pain and inflammation in microcrystalline arthropathies: experimental and clinical results.
Topics: Animals; Arthralgia; Arthritis, Experimental; Biomarkers; Calcium Pyrophosphate; Diclofenac; Dinoprostone; Durapatite; Female; Fibrinogen; Gout; Humans; Laser Therapy; Middle Aged; Rats; Tumor Necrosis Factor-alpha; Uric Acid | 2006 |
4 other study(ies) available for durapatite and diclofenac
| Article | Year |
|---|---|
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases.
Topics: Amiodarone; Animals; Binding Sites; Binding, Competitive; Cytosol; Diclofenac; Dithiothreitol; Dose-Response Relationship, Drug; Durapatite; Furosemide; Glutathione Transferase; Hydrocortisone; Hydroxyapatites; In Vitro Techniques; Iopanoic Acid; Liver; Macaca fascicularis; Mefenamic Acid; Sulfobromophthalein; Taurocholic Acid; Triiodothyronine | 1992 |
Effect of diclofenac on fixation of hydroxyapatite-coated implants. An experimental study.
Topics: Animals; Diclofenac; Drug Interactions; Durapatite; Female; Hip Prosthesis; Male; Osseointegration; Ossification, Heterotopic; Prostheses and Implants; Rabbits; Titanium; Weight-Bearing | 1994 |
Photodegradation of pharmaceutical persistent pollutants using hydroxyapatite-based materials.
Topics: Acetonitriles; Biocompatible Materials; Catalysis; Crystallization; Diclofenac; Durapatite; Environmental Monitoring; Environmental Restoration and Remediation; Fluoxetine; Oxygen; Pharmaceutical Preparations; Photolysis; Powders; Titanium; Ultraviolet Rays; Wastewater; Water Pollutants, Chemical; Water Purification | 2016 |
Nano-hydroxyapatite/carbon nanotube: An excellent anode modifying material for improving the power output and diclofenac sodium removal of microbial fuel cells.
Topics: Bacteria; Bioelectric Energy Sources; Diclofenac; Durapatite; Electrodes; Nanotubes, Carbon | 2023 |